Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.12 – $0.37
20% from low
Exchange
OTC Link
OS
Borrow rate
10.50%
Hard to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $4.5K | $6.5K | $3.3K | $1.6K | $6.9K | $30.9K | $59.1K | $35.4K |
| Gross profit | −$4.5K | −$6.5K | −$3.3K | −$1.6K | −$6.9K | −$30.9K | −$59.1K | −$35.4K |
| Gross margin | — | — | — | — | — | — | — | — |
| R&D | $0 | $0 | $0 | $793.0K | $3.5M | $2.4M | $795.2K | $681.2K |
| Operating income | −$705.4K | −$398.5K | −$1.2M | −$4.8M | −$6.3M | −$5.2M | −$1.6M | −$2.1M |
| EBITDA | −$594.4K | −$311.0K | −$1.1M | −$4.8M | −$6.3M | −$5.2M | −$1.6M | −$2.1M |
| Net income | −$730.1K | −$398.5K | −$1.2M | −$5.0M | −$6.7M | −$5.7M | −$1.6M | −$3.1M |
| Net margin | — | — | — | — | — | — | — | — |
| EPS (diluted) | -0.03 | -0.02 | -0.05 | -0.14 | -0.15 | -0.11 | -0.03 | -0.05 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $14M | $0.12 | $0.12–$0.12 | 1 |
Forward consensus · source: Financial Modeling Prep
IZOTROPIC CORP
No one on the platform currently holds IZOZF.
No tracked institution reports a position in IZOZF as of their last filing.
No one on the platform has traded IZOZF yet.
| $39M |
| — |
| CWBHFCharlotte's Web Holdings, Inc. | $0.33 | +1.51% | $53M | — |
| EMITFElbit Imaging Ltd. | $1.60 | +0.00% | $21M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
https://nfne.ws/294794 $IZOZF @izotropic #breastcancer #FDA #medicaldevice #medtech #radiology #Chemicals #Biotechnology #CSEStocks #OTC #O
View on StockTwits ↗https://nfne.ws/293628 $IZOZF @izotropic #breastcancer #FDA #medicaldevice #medtech #radiology #Chemicals #Biotechnology #CSEStocks #OTC #O
View on StockTwits ↗$IZOZF Makes Good Progress Toward Revenue Generation https://buff.ly/cvmNMHB
View on StockTwits ↗$IZOZF Already Making Strides in Africa https://buff.ly/B77cV3j
View on StockTwits ↗https://nfne.ws/285211 $IZOZF @izotropic #breastcancer #FDA #medicaldevice #medtech #radiology #Chemicals #Biotechnology #CSEStocks #OTC #O
View on StockTwits ↗$IZOZF $IZO.CSE Expands Breast Imaging Tech to Africa https://buff.ly/ZdwyVFp
View on StockTwits ↗https://nfne.ws/284237 $IZOZF @izotropic #breastcancer #FDA #medicaldevice #medtech #radiology #Chemicals #Biotechnology #Agreement #CSESto
View on StockTwits ↗https://nfne.ws/279326 $IZOZF @izotropic #breastcancer #FDA #medicaldevice #medtech #radiology #Chemicals #Biotechnology #AGM #Earnings #Re
View on StockTwits ↗$IZOZF $IZO.CSE Wonderful technology. Looks very promising. Fifth iteration of product. They have enough money to build 3 more machines. Looking for FDA approval/CE approval. They have already turned down high cost funding. They've only done funding that's allowed them to achieve key milestones. They don't want to dilute. Are looking for partners.
View on StockTwits ↗$IZOZF $IZO.CSE Initiating coverage of Izotropic, developer of the #IzoView 3D Breast CT system. The report covers technology fundamentals, regulatory progress, business model, and key risks. #MedTech #SmallCaps #EquityResearch youtu.be/gx3jEMsj5qU
View on StockTwits ↗$IZOZF $IZO.CSE: Initiating Coverage on Company with Breakthrough Technology for Women https://buff.ly/DCruX5S
View on StockTwits ↗https://nfne.ws/274123 $IZOZF @izotropic #breastcancer #FDA #medicaldevice #medtech #radiology #Chemicals #Biotechnology #CSEStocks #OTC #O
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.